可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Gerschlick AH, Baron J. Dealing with instent restenosis[J]. Heart, 1998, 79: 319-323.
[2]Bhatia V, Bhatia R, Dhindsa S. Drugeluting intracoronary stents: have we got the magic bullet[J]. J Postgrad Med, 2003, 49(3): 291- 296.
[3]Strehlow K,Werner N, Berweiler J,et al. Estrogen increases bone marrowderived endothelial progenitor cell production and diminishes neointima formation[J]. Circulation, 2003, 107: 3059-3065.
[4]Brouchet L, Krust A, Dupont S, et al. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptoralpha but not estrogen receptorbeta[J]. Circulation, 2001,103:423-428.
[5]Krasinski K, Spyridopoulos I, Asahara T, et al. Estradiol accelerates functional endothelial recovery after arterial injury[J]. Circulation, 1997, 95: 1768-1772.
[6]Stirone C, Chu Y, Sunday L, et al. 17 Betaestradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: Quantification by realtime polymerase chain reaction[J]. Eur J Pharmacol, 2003, 478(1):35-38.
[7]Hayashi T, Yamada K, Esaki T, et al. Estrogen increases endothelial nitric oxide by a receptormediated system[J]. Biochem Biophys Res Commun, 1995, 214(3): 847-855.
[8]Dubey RK, Jackson EK, Gillespie DG, et al. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogenactivated protein kinase activity[J]. Arterioscler Thromb Vasc Biol, 2000, 20(4): 964-972.
[9]Amant C, Holm P, Xu SH, et al. Estrogen receptormediated, nitric oxidedependent modulation of the immunologic barrier function of the endothelium: regulation of fas ligand expression by estradiol[J]. Circulation, 2001, 104:2576-2581.
[10]Fischer GM, Swain ML. Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats[J]. Am J Physiol, 1977, 232(6): H617-H621.
[11]Adams MR,Kaplan JR,Manuck SB,et al. Inhibition of coronary artery atherosclerosis by 17beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone[J]. Arteriosclerosis, 1990, 10(6): 1051-1057.
[12]Li G, Chen YF, Greene GL, et al. Estrogen inhibits vascular smooth muscle celldependent adventitial fibroblast migration in vitro[J]. Circulation,1999, 100:1639-1645.
[13]Hoetzer GL, Stauffer BL, Irmiger HM, et al. Acute and chronic effects of oestrogen on endothelial tissuetype plasminogen activator release in postmenopausal women[J]. J Physiol, 2003, 551(Pt 2):721-728.
[14]White CR, Shelton J, Chen SJ, et al. Estrogen restores endothelial cell function in an experimental model of vascular injury[J]. Circulation, 1997, 96: 1624-1630.
[15]Baskaran C, Stanley N, JeanFranc, et al. Coronary artery endothelial protection after local delivery of 17betaestradiol during balloon angioplasty in a porcine model: A potential new pharmacologic approach to improve endothelial function[J]. J Am Coll Cardiol, 2001, 38(5): 1570-1576.
[16]New G, Moses JW, Roubin GS, et al. Estrogeneluting, phosphorylcholinecoated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model[J]. Cathet Cardiovasc Intervent,2002, 57:266-271.
[17]Abizaid A, Albertal M, Costa MA, et al. First human experience with the 17beta estradiol eluting stent: The estrogen and stents to eliminate restenosis (EASTER) trial[J]. J Am Coll Cardiol, 2004, 43(6):1118-1121.